Home > KNOWLEDGE > Content

Infectious disease screening method

Jan 12, 2018

A schematic diagram of the HIV testing card-type structure of infectious disease testing reagents produced by Chur Company illustrates the reaction principle and process: If the serum contains a certain amount of HIV-1 type antibody or HIV-2 type antibody, HIV antibodies in serum and gold standard recombinant gp41 antigen and gp36 antigen immunoprecipitation occurred complex. Upon chromatography onto the test line (T1 line or T2 line), the complex then immunosorbates to the recombinant gp36 antigen embedded in the T1 line or to the recombinant gp36 antigen on the T2 line to bridge the colloidal gold color on the T1 or T2 lines , The remaining gold standard continued to chromatogram to the control line (C line), the gold standard and embedded here polyclonal anti-immune reaction and color, that is, T line and C line were colored for the red band, indicating that the blood Contains HIV antibody; if the serum does not contain HIV antibody or less than a certain amount, T1 or T2 at the recombinant gp41 antigen or gp36 antigen does not react, T line is not color, and C line at the multi-resistance and gold standard Immune reaction and color, indicating that the blood does not contain HIV antibodies.

Hangzhou Laihe Biotech Co., Ltd. (hereafter referred to as “Laihe Biotech”) is a life science company specialized in R & D, manufacturing, marketing and service in point-of-care testing, monitoring and health technology industry, is committed to provide fast, accurate and reliable health detection products and services.

Contact: Helen

Tel: +86-571-86658003

Fax: +86-571-86658000

E-mail: office@lyher.com